Comments from medtech stakeholders in all geographies are invited until 28 September on the Chinese State Food and Drug Administration’s draft Medical Device Administration Law (MDAL). The law is set to replace the medical devices supervision and administration regulation issued since 2000, most recently No. 739 in 2021.
It would be China’s first national level law governing medical devices. The MDAL would have purview over the total medical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?